Genetic factors for the severity of ACPA-negative rheumatoid arthritis in 2 cohorts of early disease: A genome-wide study

Journal of Rheumatology

Volumn 42, Issue 8, 2015, Pages 1383-1391

  De Rooy, Diederik P C ^a   Tsonaka, Roula ^a   Andersson, Maria L E ^b   Forslind, Kristina ^b   Zhernakova, Alexandra ^a,c   Frank Bertoncelj, Mojca ^d   De Kovel, Caroline G F ^e   Koeleman, Bobby P C ^e   Van Der Heijde, Désirée M F M ^a   Huizinga, Tom W J ^a   Toes, René E M ^a   Houwing Duistermaat, Jeanine J ^a   Ospelt, Caroline ^d   Svensson, Björn ^c   Van Der Helm Van Mil, Annette H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autoantibodies; Genetic studies; Joint erosions; Rheumatoid arthritis

Indexed keywords

ANTICITRULLINATED PROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; ARTICLE; CHROMOSOME 21; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEREDITY; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; HUNK GENE; JOINT DESTRUCTION; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCAF4 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; ARTHRITIS, RHEUMATOID; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HAND JOINT; IMMUNOLOGY; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84940658761     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140741     Document Type: Article

References (38)

1. van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 2008;58:53-60.
2. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005;7:R949-58.
3. Viatte S, Plant D, Bowes J, Lunt M, Eyre S, Barton A, et al. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann Rheum Dis 2012; 71:1984-90.
4. Knevel R, Grondal G, Huizinga TW, Visser AW, Johnsson H, Vikingsson A, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann Rheum Dis 2012;71:707-9.
5. Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012;44:1336-40.
6. De Rooy DP, van der Linden MP, Knevel R, Huizinga TW, Van der Helm-van Mil AH. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 2011;50:93-100.
7. van der Heijde D, Boers M, Lassere M. Methodological issues in radiographic scoring methods in rheumatoid arthritis. J Rheumatol 1999;26:726-30.
8. Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafstrom I. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum 2005;52:3360-70.
9. Bossini-Castillo L, de Kovel C, Kallberg H, van't Slot R, Italiaander A, Coenen M, et al. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Ann Rheum Dis 2015;74:e15.
10. Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, et al. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol 2013;42:182-9.
11. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1984;38:963-74.
12. Clayton D, Leung HT. An R package for analysis of whole-genome association studies. Hum Hered 2007;64:45-51.
13. Pinheiro J, Bates D, DebRoy S, Sarkar D, and R-Core Team. Linear and nonlinear mixed effects models. R package version 3.1-117 (2014). [Internet. Accessed March 10, 2015.] Available from: http://CRAN.R-project.org/package=nlme
14. R-Core Team. The R Project for statistical computing, Vienna, Austria (2014). [Internet. Accessed March 10, 2015.] Available from: www.R-project.org
15. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-75.
16. Gower JC. Some distance properties of latent root and vector methods used in multi-variate analysis. Biometrika 1966;53:325-8.
17. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
18. Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, et al. Ensembl 2014. Nucleic Acids Res 2014;42:D749-55.
19. Yeh ES, Yang TW, Jung JJ, Gardner HP, Cardiff RD, Chodosh LA. Hunk is required for HER2/neu-induced mammary tumorigenesis. J Clin Invest 2011;121:866-79.
20. Gross SS, Brent MR. Using multiple alignments to improve gene prediction. J Comput Biol 2006;13:379-93.
21. Haas BJ, Delcher AL, Mount SM, Wortman JR, Smith RK Jr, Hannick LI, et al. Improving the Arabidopsis genome annotation using maximal transcript alignment assemblies. Nucleic Acids Res 2003;31:5654-66.
22. Burge C, Karlin S. Prediction of complete gene structures in human genomic DNA. J Mol Biol 1997;268:78-94.
23. Korf I, Flicek P, Duan D, Brent MR. Integrating genomic homology into gene structure prediction. Bioinformatics Suppl 2001;17 Suppl 1:S140-8.
24. Yamasaki C, Murakami K, Takeda J, Sato Y, Noda A, Sakate R, et al. H-InvDB in 2009: extended database and data mining resources for human genes and transcripts. Nucleic Acids Res 2010; 38:D626-32.
25. Imanishi T, Itoh T, Suzuki Y, O'Donovan C, Fukuchi S, Koynagi KO, et al. Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol 2004;2:e162.
26. van Baren MJ, Brent MR. Iterative gene prediction and pseudogene removal improves genome annotation. Genome Res 2006;16:678-85.
27. McAllister K, Yarwood A, Bowes J, Orozco G, Viatte S, Diogo D, et al. Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data. Arthritis Rheum 2013;65:3058-62.
28. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-14.
29. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009;41:1313-8.
30. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506:376-81.
31. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659-72.
32. Van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008;10:205.
33. de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, et al. Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts. Ann Rheum Dis 2014;73:1384-7.
34. Huizinga TW, Amos CL, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D. Refining the complex rheumatoid arthritis genotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005;52:3433-8.
35. De Rooy DP, Willemze A, Mertens B, Huizinga TW, Van der Helm-van Mil AH. Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes? Arthritis Res Ther 2011;13:R180.
36. Trynka G, Sandor C, Han B, Xu H, Stranger BE, Liu XS, et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet 2013;45:124-30.
37. Courtial N, Smink JJ, Kuvardina ON, Leutz A, Gothert JR, Lausen J. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J 2012;26:523-32.
38. Ensembl genome database project. Transcript: AP000255.6-001. [Internet. Accessed March 10, 2015.] Available from: http://uswest.ensembl.org/Homo-sapiens/Transcript/Summary?t=ENST00000610276;r=21:33108045-33108720;g=ENSG00000273091;redirect=no